Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
MICHAEL TEUT/MARTIN DINGES/ROBERT JÜTTE (Hg.), Religiöse Heiler im medizinischen Pluralismus in Deutschland (MedGG-Beiheft71). Franz Steiner Verlag, Stuttgart 2019, 139 S.
View through CrossRef
MICHAEL TEUT/MARTIN DINGES/ROBERT JÜTTE (Hg.), Religiöse Heiler im medizinischen Pluralismus in Deutschland (MedGG-Beiheft71). Franz Steiner Verlag, Stuttgart 2019, 139 S.
Title: MICHAEL TEUT/MARTIN DINGES/ROBERT JÜTTE (Hg.), Religiöse Heiler im medizinischen Pluralismus in Deutschland (MedGG-Beiheft71). Franz Steiner Verlag, Stuttgart 2019, 139 S.
Description:
MICHAEL TEUT/MARTIN DINGES/ROBERT JÜTTE (Hg.
), Religiöse Heiler im medizinischen Pluralismus in Deutschland (MedGG-Beiheft71).
Franz Steiner Verlag, Stuttgart 2019, 139 S.
Related Results
COMPUTING STEINER POINTS AND PROBABILITY STEINER POINTS IN ℓ1 AND ℓ2 METRIC SPACES
COMPUTING STEINER POINTS AND PROBABILITY STEINER POINTS IN ℓ1 AND ℓ2 METRIC SPACES
The Steiner tree problem is a well known network optimization problem which asks for a connected minimum network (called a Steiner minimum tree) spanning a given point set N. In th...
If I Had Possession over Judgment Day: Augmenting Robert Johnson
If I Had Possession over Judgment Day: Augmenting Robert Johnson
augmentvb [ɔːgˈmɛnt]1. to make or become greater in number, amount, strength, etc.; increase2. Music: to increase (a major or perfect interval) by a semitone (Collins English Dicti...
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
This randomized clinical trial explores whether hormone intensification at start of androgen deprivation therapy alters selection of androgen receptor (AR) gene alterations within ...
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Background:
Apolipoprotein B (apoB) provides an integrated measure of atherogenic risk. Whether apoB levels and apoB lowering hold incremental predictive information on...
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
IMPORTANCE
Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19.
...
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
OBJECTIVE
In observational data, lower levels of lipoprotein(a) have been associated with greater prevalence of type 2 diabetes. Whether pharmacologic lowering of...
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Abstract
The ODYSSEY OUTCOMES trial, comprising over 47 000 patient-years of placebo-controlled observation, demonstrated important reductions in the risk of recurre...
Intravenous Vitamin C for Patients Hospitalized With COVID-19
Intravenous Vitamin C for Patients Hospitalized With COVID-19
ImportanceThe efficacy of vitamin C for hospitalized patients with COVID-19 is uncertain.ObjectiveTo determine whether vitamin C improves outcomes for patients with COVID-19.Design...